Avanos Medical
AVNS
297 hedge funds and large institutions have $1.52B invested in Avanos Medical in 2021 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 81 increasing their positions, 65 reducing their positions, and 32 closing their positions.
34,467% more call options, than puts
Call options by funds: $2.07M | Put options by funds: $6K
78% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 32
25% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 65
11% more capital invested
Capital invested by funds: $1.36B → $1.52B (+$156M)
8% more funds holding
Funds holding: 274 → 297 (+23)
0.24% more ownership
Funds ownership: 90.82% → 91.06% (+0.24%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$31.3M |
| 2 |
RC
RGM Capital
Naples,
Florida
|
+$13.2M |
| 3 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$10.7M |
| 4 |
BlackRock
New York
|
+$10.3M |
| 5 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$6.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$65.5M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$29.4M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$6.84M |
| 4 |
Renaissance Technologies
New York
|
-$4.13M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.48M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
301
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$194 | +6 | New |
|
|
JWA
302
JFS Wealth Advisors
Hermitage,
Pennsylvania
| – | +$356 | +11 | New |
|
|
BAM
303
Byrne Asset Management
Kingston,
New Jersey
| – | +$388 | +12 | New |
|
|
SCA
304
Snowden Capital Advisors
New York
| – | +$808 | +25 | New |
|
AVNS Hedge Fund Activity: Q4 2021 in Review
297 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2021, worth a combined $1.52B — up 11% from $1.36B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new AVNS positions and 32 closed out — a net gain of 25 holders — while 81 added to existing stakes and 65 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $31.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $65.5M.
- 297 institutional investors held Avanos Medical (AVNS) as of Q4 2021, up from 274 in Q3 2021.
- Funds reported $1.52B of Avanos Medical stock for Q4 2021, up 11% quarter-over-quarter.
- 57 funds opened new Avanos Medical positions in Q4 2021 and 32 closed out, a net change of +25 holders.
- The largest Avanos Medical buyer in Q4 2021 was Wellington Management Group, an estimated $31.3M added.
- The largest Avanos Medical seller in Q4 2021 was T. Rowe Price Associates, an estimated $65.5M sold.
Based on aggregated 13F filings for Q4 2021.